NanoViricides Inc. (NNVC)

[KMBJN]

Yes, they completed an IND in India / DCGI for their trial, as we have discussed before.

Hopefully they can get a deal with a big pharma to do a trial in US for Covid or RSV, and file an IND with the FDA.

We believe that upon completion of the Phase 1a/1b human clinical trials of NV-CoV-2, the NV-387 oral formulations will be eligible for (i) Phase II/III clinical trials for RSV, (ii) Phase II clinical trials for COVID, and (iii) Phase II clinical trials for “Long COVID” associated with residual virus. We are currently in discussions with field experts regarding the strategy of prioritization for further development of NV-387 towards approval.

...

Importantly, in the reported quarter, we have approximately doubled our production batch size and capacity for NV-387 manufacture. We believe that this capacity will be sufficient for Phase II clinical trials for COVID or Phase II/III clinical trials for RSV. The production program for Phase II clinical supply is expected to be commissioned soon.

But yeah, so much for all those predictions that (1) they are unable to produce consistent batches of significant quantity to run a trial, because of "physics"; (2) they never intended to and never would ever run any trial, a supposed first hand account / knowledge of fraud; or (3) "in all the history of drug development, there has never been an instance of failing to get an IND and run a trial for xxx years, that a company got an IND and ran a trial" repeated several hundred times here by one poster!

There are many reasons to be skeptical, but it's good to be balanced and acknowledge that NNVC does appear to actually be trying to run clinical trials and get their drugs to market, ........... f i n a l l y .... after a loooooooooong time f*ing around.

Since they have only proven safety so far, now on to the important question investors want to know - do the 'cides actually work in humans? similar to as they have in many preclinical models? That will be a bit longer to get that answer, as they appear to still be in discussions to find suitable sites to recruit Covid subjects for the trial.